RNA-Seq – News and Features

Scientists at the University of Vienna have identified potential multipotent stem cells in the sea anemone Nematostella vectensis. These cells, regulated by ancient conserved genes, allow the anemone to regenerate and potentially avoid aging.

Researchers found a new class of RNA in blood nanoparticles, potentially paving the way for less invasive cancer diagnosis. They used next-generation RNA sequencing and other innovative tools to develop a cost-effective liquid biopsy test.

An international research team has discovered and described a new type of beige fat cells, which differ from the ones that were already known. The cells consume energy and produce heat through seemingly pointless biochemical reactions.

Scientists at St. Jude Children’s Research Hospital, the Peter Doherty Institute for Infection and Immunity, and others reveal high expression of OLAH drives life-threatening immune responses.

The new study identifies 4,248 CpG sites associated with the risk of seven different types of cancer: breast, colorectal, renal cell, lung, ovarian, prostate and testicular germ cell cancers.

Meteorin-like (METRNL) protein saps energy from T cells, thereby severely limiting their ability to fight cancer, according to new research. Blocking METRNL signaling may allow immune cells to regain the energy necessary to eliminate tumors.

Researchers from Yale School of Medicine examined the effects of human milk versus formula on intestinal health using organoids. Their study revealed that parental milk promotes epithelial growth and differentiation.

Strokes lead to irreversible damage to the brain. As the cellular reactions to a cerebral infarction are not yet fully understood, there is a lack of possible approaches to promote the regeneration of damaged nerve tissue in the brain

In this interview, we spoke to Jason Koth, product management lead at Scale Biosciences, to learn more about their new ScalePlex technology for leveraging and overcoming current limitations within single-cell genomics.

A new small molecule could alleviate pain for sickle cell disease patients who don't respond to hydroxyurea.